Profilo
Danielle Glenn served as the Chief Investment Officer at OrbiMed Advisors LLC.
She then worked as the Chief Financial Officer at Arctic Bioscience AS from 2020 to 2022.
Following that, she held the position of Chief Investment Officer at Bywater Capital Ltd. In 2022, she became the Chief Financial Officer & Head-Investor Relations at Zwipe AS.
Ms. Glenn completed her undergraduate degree at Harvard University.
Precedenti posizioni note di Danielle Glenn
| Società | Posizione | Fine |
|---|---|---|
| ZWIPE | Direttore Finanziario/CFO | 01/02/2024 |
| ARCTIC BIOSCIENCE | Direttore Finanziario/CFO | 31/03/2022 |
OrbiMed Advisors LLC
OrbiMed Advisors LLC Investment ManagersFinance OrbiMed generally seeks long-term capital appreciation through investments in companies in the global healthcare sector. | Direttore degli Investimenti | - |
Bywater Capital Ltd. | Direttore degli Investimenti | - |
Formazione di Danielle Glenn
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Società collegate
| Aziende private | 5 |
|---|---|
OrbiMed Advisors LLC
OrbiMed Advisors LLC Investment ManagersFinance OrbiMed generally seeks long-term capital appreciation through investments in companies in the global healthcare sector. | Finance |
Harvard University
Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Zwipe AS
Zwipe AS Computer PeripheralsElectronic Technology Develops and markets biometric contactless payment cards | Electronic Technology |
Arctic Bioscience AS
Arctic Bioscience AS Pharmaceuticals: MajorHealth Technology Manufactures and wholesales nutraceutical & pharmaceutical products | Health Technology |
Bywater Capital Ltd. |
















